The prevention and treatment of cytomegalovirus infection after liver transplantation.
- Author:
Shu-sen ZHENG
1
;
Zhi-jun JIANG
;
Xiao XU
;
Ting-bo LIANG
;
Wei-lin WANG
;
Yan SHEN
;
Min ZHANG
;
An-wei LU
Author Information
- Publication Type:Journal Article
- MeSH: Adult; Antigens, Viral; blood; Antiviral Agents; therapeutic use; Cytomegalovirus; immunology; Cytomegalovirus Infections; prevention & control; Female; Ganciclovir; therapeutic use; Humans; Liver Transplantation; adverse effects; Male; Middle Aged; Postoperative Complications; prevention & control; Retrospective Studies
- From: Chinese Journal of Surgery 2005;43(9):584-586
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVETo review diagnosis and treatment experience of cytomegalovirus (CMV) infection after liver transplantation.
METHODSThe clinical data of 96 patients receiving liver transplantation in our hospital from January 2001 to December 2002 were analyzed retrospectively.
RESULTSCMV infection occurred in 19 patients, blood IE-E antigen of CMV and PP65 antigen of CMV was detected in all the patients with CMV infection, 8 patients with CMV-IgM positivity, 3 of them presented with dyspnea, 4 with fever and 2 with jaundice, 14 patients had no symptoms of CMV infection. IE-E antigen of CMV and PP65 antigen of CMV in blood of 18 patients became negative after treatment with ganciclovir, 1 patients died from interstitial pneumonitis.
CONCLUSIONSCytomegalovirus infection after liver transplantation is associated with many factors, the key point of CMV infection is prevention actively and early treatment after operation. The detection of blood antigen of CMV is necessary for early diagnosis and guiding treatment of CMV infection, ganciclovir is effective for treatment of CMV infection.
